TY - JOUR
T1 - Financial burden, distress, and toxicity in cardiovascular disease
AU - Slavin, Samuel D.
AU - Khera, Rohan
AU - Zafar, S. Yousuf
AU - Nasir, Khurram
AU - Warraich, Haider J.
N1 - Funding Information:
YZ is on the advisory board of AIM Specialty Health, Vivor, LLC, and SamFund, on the board of directors of Family Reach Foundation, a board member of Corpenicus-WCG IRB, a consultant for RTI, McKesson, Quintiles, and Discern, LLC, and receives research funding from the NIH and AstraZeneca. SS, RK, KN, and HW have no disclosures.
Publisher Copyright:
© 2021
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/8
Y1 - 2021/8
N2 - Cardiovascular disease (CVD) is a major source of financial burden and distress, which has 3 main domains: (1) psychological distress; (2) cost-related care non-adherence or medical care deferral, and (3) tradeoffs with basic non-medical needs. We propose 4 ways to reduce financial distress in CVD: (1) policymakers can expand insurance coverage and curtail underinsurance; (2) health systems can limit expenditure on low-benefit, high-cost treatments while developing services for high-risk individuals; (3) physicians can engage in shared-decision-making for high-cost interventions, and (4) community-based initiatives can support patients with system navigation and financial coping. Avenues for research include (1) analysis of how healthcare policies affect financial burden; (2) comparative effectiveness studies examining high and low-cost strategies for CVD management; and (3) studying interventions to reduce financial burden, financial coaching, and community health worker integration.
AB - Cardiovascular disease (CVD) is a major source of financial burden and distress, which has 3 main domains: (1) psychological distress; (2) cost-related care non-adherence or medical care deferral, and (3) tradeoffs with basic non-medical needs. We propose 4 ways to reduce financial distress in CVD: (1) policymakers can expand insurance coverage and curtail underinsurance; (2) health systems can limit expenditure on low-benefit, high-cost treatments while developing services for high-risk individuals; (3) physicians can engage in shared-decision-making for high-cost interventions, and (4) community-based initiatives can support patients with system navigation and financial coping. Avenues for research include (1) analysis of how healthcare policies affect financial burden; (2) comparative effectiveness studies examining high and low-cost strategies for CVD management; and (3) studying interventions to reduce financial burden, financial coaching, and community health worker integration.
KW - Cardiovascular Diseases/economics
KW - Community Health Workers/organization & administration
KW - Comparative Effectiveness Research
KW - Decision Making, Shared
KW - Financial Stress/economics
KW - Health Care Costs
KW - Health Expenditures
KW - Humans
KW - Insurance Coverage
KW - Needs Assessment/economics
KW - Treatment Outcome
UR - http://www.scopus.com/inward/record.url?scp=85107428199&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85107428199&partnerID=8YFLogxK
U2 - 10.1016/j.ahj.2021.04.011
DO - 10.1016/j.ahj.2021.04.011
M3 - Review article
C2 - 33961830
AN - SCOPUS:85107428199
SN - 0002-8703
VL - 238
SP - 75
EP - 84
JO - American Heart Journal
JF - American Heart Journal
ER -